Pune Study Shows Offline AI Can Expand Eye Screening
A Pune-based clinical study has found that an offline artificial intelligence system integrated with smartphone-based retinal imaging can identify signs of diabetic retinopathy, glaucoma and age-related macular degeneration. The findings point to a possible way of extending basic eye screening beyond hospitals, particularly in rural and underserved communities where specialist services and reliable internet access remain limited.
Published in the European Journal of Ophthalmology, the study assessed the diagnostic performance of an AI system designed to analyse retinal photographs without relying on cloud connectivity. Researchers examined 371 eyes from 193 adults in Pune, using images captured through a smartphone-compatible fundus camera. The technology’s offline capability is significant for healthcare delivery outside major urban centres. Many screening programmes depend on transferring medical images to remote servers for analysis, creating challenges where mobile networks are weak or unavailable. An on-device system can process images locally, potentially allowing frontline health workers to identify patients who require further examination. The approach could be particularly relevant for organised screening camps and teleophthalmology programmes. Instead of replacing ophthalmologists, such systems can act as an initial screening layer, helping identify people who may need referral to specialist care. This distinction is important because an AI screening result does not by itself constitute a complete clinical diagnosis.
The Pune study focused on three major eye conditions: diabetic retinopathy, glaucoma and age-related macular degeneration. These diseases can cause significant vision loss, while early detection can improve the opportunity for timely treatment or monitoring. However, expanding the system to additional conditions would require separate algorithm development, clinical validation and regulatory clearances. The study also highlights a broader urban-rural healthcare infrastructure gap. Specialist eye care is concentrated in larger cities, while people in smaller towns and villages can face longer journeys and higher costs to access diagnostic services. Portable imaging combined with offline analysis could reduce one part of that access barrier, although follow-up treatment and specialist referral would still depend on local healthcare capacity.
The system evaluated in the study has received regulatory approval in India for clinical use and European Class II medical-device certification, according to the study information. Its effectiveness in wider populations will depend on continued validation across different settings, patient groups and image quality conditions. For cities such as Pune, the implications extend beyond medical technology. Digital health tools can reduce pressure on specialist facilities when integrated with primary care and referral networks. The larger test will be whether AI eye screening can move from controlled clinical settings into affordable, reliable community healthcare without creating new gaps between those who can access follow-up treatment and those who cannot.
